Entasis: Innoviva Completes Acquisition of Entasis Therapeutics

(marketscreener.com) Innoviva, Inc. , a diversified holding company with a portfolio of royalties, today announced the successful completion of its acquisition of Entasis Therapeutics Holdings Inc. , an advanced late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products. Entasis brings to Innoviva an...https://www.marketscreener.com/quote/stock/INNOVIVA-INC-25641616/news/Innoviva-Completes-Acquisition-of-Entasis-Therapeutics-40954675/?utm_medium=RSS&utm_content=20220711